Illumisoft Lighting Corp. · TSXV:UVC
Illumisoft Lighting — Investor Presentation (October 2026)
18 slides from Illumisoft Lighting's investor presentation, October 2026
Slide 1: Revolutionizing indoor health through light
Revolutionizing indoor health through light I N V E S TO R P R E S E N TAT I O N TSX-V : UVC OTCQB : FUVCF October 2026
Slide 2: Important disclosures
LEGAL NOTICE Important disclosures. F O R WA R D - L O O K I N G I N F O R M AT I O N I N D U S T R Y A N D M A R K E T D ATA This presentation contains "forward-looking information" within the meaning of applicable Canadian securities laws and Market data, statistics, and forecasts cited herein are
Slide 3: We solved fire. We solved water. We never solved air.
THE PROBLEM We solved fire. We solved water. We never solved air. Healthcare-acquired infections in Canada, every year. 473,590 Infections caught in Canadian hospitals. C$29.3B C$19.85B Lost hospital-bed capacity annual burden C$9.47B 33,151 Treatment costs Deaths linked to those infections. W H AT
Slide 4: When antibiotics stop working, prevention has to.
A N T I B I O T I C R E S I S TA N C E When antibiotics stop working, prevention has to. 1.27M 39M 136M Deaths directly caused by resistant bacterial Deaths projected from resistant infections, 2025 Healthcare-associated resistant infections every infections in 2019. to 2050. year. UP TO, IN INDEPEN
Slide 5: Standards are tightening. Canada moved first.
WHY NOW Standards are tightening. Canada moved first. Standards, procurement, liability and preparedness, 2024 to 2026. INDEPENDENT VIEW Indoor air is a health crisis “ 1 Indoor transmission drives the burden, and clean-air expectations have moved. Far-UVC represents one of the highest-leverage fund
Slide 6: Proven today. Coming next. Earning now.
ILLUMISOFT’S SOLUTION Proven today. Coming next. Earning now. SaniLume SaniLux ECOWing COMMERCIAL GUV FA R - U V C I N D E V E L O P M E N T COMMERCIAL LIGHTING AC T IV E CO MIN G SO ON RE VE NU E PRO D U CI NG 201 to 1,994 eACH 216 nm 34 of 50 Every other device tested at Leeds: 17.1 or less. Desig
Slide 7: Backed by people who built at global scale.
THE PEOPLE BEHIND IT Backed by people who built at global scale. Chris Anderson Rob Reid Dr. Jonathan Ketcham Bill Weber Capgemini TED / INVESTOR RHAPSODY / ADVISOR S T R AT E G I C A D V I S O R C H I E F S T R AT E G Y O F F I C E R P R O D U C T PA R T N E R Took TED Talks to a Technology investo
Slide 8: The best UV device tested in the Leeds chamber.
S A N I L U M E / AVA I L A B L E T O D AY The best UV device tested in the Leeds chamber. 254 nm upper-room UV. It treats the air while the room stays in use. AIR CHANGES PER HOUR, INDEPENDENT CHAMBER TESTING 201 to 1,994 eACH Every other device tested in the same chamber: 0.003 to 17.1. SaniLume 1
Slide 9: Prevention pays. SaniLume delivers it.
COMMERCIAL CASE Prevention pays. SaniLume delivers it. Modelled by CHAIR, the coalition behind our two hospital deployments. THE GAP O N E T E R T I A R Y H O S P I TA L U N I T S P E R H O S P I TA L Our market model assumes 10.5% 3% 972 units 100 One tertiary facility needs To outfit a single Cana
Slide 10: A new source. A broader ambition.
S A N I L U X / D E S I G N TA R G E T S A new source. A broader ambition. 216 nm Proprietary nanoengineered Far-UVC. Core IP owned by Illumisoft. IN D EV E LO PM E NT / O W N ED I P No filter. No gas. No 10x 1W 0 to 100% licence. Far-UVC per dollar, target Far-UVC output, design target Output contr
Slide 11: From breakthrough science to products built for real life.
CAPGEMINI / GLOBAL SCALE From breakthrough science to products built for real life. Delivered through frog and Synapse, part of Capgemini. EUR 22.5B 417,600 50+ Global revenue People worldwide Countries Full year 2025 As at 30 June 2026 Global operations 1 Design for use 2 Engineer to build 3 Prepar
Slide 12: 34 of the top 50. In one portfolio.
E C O W I N G / T H E C O M M E R C I A L F O U N D AT I O N 34 of the top 50. In one portfolio. 167 lm/W of DLC-listed efficiency, engineered and manufactured in Ottawa. The revenue base and the warm channel into both UV platforms. RE VE NU E P RO D UCI NG 167 lm/W 60 to 75% 5 min 50,000 h 17 40 to
Slide 13: Hospitals first. Then every room people share.
THE OPPORTUNITY Hospitals first. Then every room people share. $9.7B ~$8B $5.25B SaniLume ECOWing SaniLux Hospital serviceable addressable North American LED retrofit market. Phase 1: hospitals and aviation. market. 230K x 12 units. Source cites $96M at 1%. Top five players hold about 20%. Phase 2 s
Slide 14: The next milestones are already in motion.
W H AT H A P P E N S N E X T The next milestones are already in motion. Company targets and stated next steps. Timing depends on partners and approvals. T O D AY IN PROGRESS IN PROGRESS NEXT Q 1 2 0 2 7 TA R G E T 1 2 3 4 Convert the program Engineer SaniLux Open the US channel First SaniLux unit CH
Slide 15: Science, commercialization and adoption.
LEADERSHIP AND ADOPTION Science, commercialization and adoption. Ehsan Agahi Bill Weber Dr. Michael Johnson Ali Pickett CHIEF EXECUTIVE OFFICER C H I E F S T R AT E G Y O F F I C E R CHIEF TECHNOLOGY OFFICER CHIEF FINANCIAL OFFICER Zephyr Venture Partners. Biotech and life- Former New Growth Venture
Slide 16: Capitalization and capital deployment.
C A P I TA L S T R U C T U R E Capitalization and capital deployment. S H A R E S O U T S TA N D I N G USE OF PROCEEDS Issued common shares 46,173,389 ~35% Manufacturing and inventory scale Options 3,540,000 ~30% Sales and channel expansion, CA and USE OF Finder warrants 425,390 US PROCEEDS ~20% F U
Slide 17: Six reasons. Why Illumisoft.
INVESTMENT THESIS Six reasons. Why Illumisoft. Structural demand 1 4 Mission-aligned backers Standards 19.43% CSA Z8000:24 and Z317.12:25 put engineered air disinfection Held by Chris Anderson and Rob Reid through Resilience in front of Canadian healthcare planners. Reserve. Validated performance 2
Slide 18: Safer air. Better health. Better future.
Safer air. Better health. Better future. WEB C O N TA C T REGISTERED LISTINGS illumisoft.com info@illumisoft.com Ottawa, Canada TSX-V : UVC / OTCQB : FUVCF
Illumisoft Lighting — Investor Presentation (October 2026) on 6ix